🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate whether a reduction in the radiation dose and fiel...
Status
Completed
Location
Durham Regional Hospital
Start Date
2010-09-20
Trial ID
NCT01186978
Treatments Being Tested
This randomized phase II trial studies how well high or standard intensity ...
Status
Terminated
Location
Kaiser Permanente Oakland-Broadway
Start Date
2013-08
Trial ID
NCT01921751
This study hypothesizes that approximately 50% of rectal cancer patients ca...
Status
Recruiting
Location
Nacional Cancer Institute
Start Date
2025-01-06
Trial ID
NCT06758830
Many trials that patients with advanced or recurrent indolent lymphoma mana...
Status
Unknown
Location
DiDeng
Start Date
2015-10
Trial ID
NCT02438501
Treatments Being Tested
The central hypothesis is to test Low Dose Fraction Radiotherapy (LDFRT), a...
Status
Unknown
Location
Multiple Locations
Start Date
2012-10-01
Trial ID
NCT03890185
Treatments Being Tested
RATIONALE: Radiation therapy uses high energy x-rays to damage tumor cells....
Status
Completed
Location
Long Beach Memorial Medical Center
Start Date
1996-12
Trial ID
NCT00002875
The overall objective is to demonstrate preliminary efficacy of APX005M-car...
Status
Withdrawn
Location
NSGO-CTU
Start Date
2023-09-07
Trial ID
NCT05201001
Treatments Being Tested
Carboplatin, nab-paclitaxel, and nivolumab combination will be administered...
Status
Completed
Location
University of Chicago Medical Center
Start Date
2017-06-27
Trial ID
NCT03107182
This randomized phase III trial studies pelvic radiation therapy to see how...
Status
Unknown
Location
University of Alabama at Birmingham Cancer Center
Start Date
2009-03-23
Trial ID
NCT00807768
This phase II study will evaluate whether a reduction in radiation dose and...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2019-02-13
Trial ID
NCT03681535
Treatments Being Tested